Skip to content

Cancer Care: The risk factors of venous access failure.

Cancer Care: The risk factors of venous access failure. A prospective observational study of peripheral and central venous catheter outcomes among adult patients within a tertiary care setting.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617000438358
Acronym
CARETaKER
Enrollment
200
Registered
2017-03-27
Start date
2017-10-20
Completion date
2019-02-13
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This observational study will evaluate causes of catheter failure in cancer care patients. Who is it for? You may be eligible to join this study if you are aged 18 years or above, have been admitted to a cancer care service inpatient unit, and have had a peripheral venous catheter (PVC) inserted within 48 hours of admission. Study details All participants in this study will be reviewed by a research nurse second daily throughout their hospital admission. Information will be collected about risk factors, such as antibiotic use, flushing regime, dressing types and catheter types; and catheter related outcomes such as PVC failure, insertion of a Central Venous Access Device (CVAD), adverse events, and hospital length of stay. Participants in the study who experience peripheral catheter failure will be compared against those who did not, to identify the risk factors associated with this failure and how this can be mitigated. Patients who go on to receive Central Venous Access Devices (CVADs) will also be compared to those who do not, in order to explore the decision-making processes that go into transitioning to long-term devices (as well as the outcomes of these decisions e.g. CVAD success or failure).

Interventions

Patients with a peripheral intravenous catheter admitted to cancer care services unit, within the preceding 48 hour period will be identified prospectively. Consenting patients will have demographic data collected: e.g. admitting diagnosis, co-morbidities, skin and vein condition, cannula insertion details. Participants will be reviewed by a research nurse second daily and collect other risk factors including (but not limited to): antibiotic use, type and dosage, flushing regime, continuous or i

Patients with a peripheral intravenous catheter admitted to cancer care services unit, within the preceding 48 hour period will be identified prospectively. Consenting patients will have demographic data collected: e.g. admitting diagnosis, co-morbidities, skin and vein condition, cannula insertion details. Participants will be reviewed by a research nurse second daily and collect other risk factors including (but not limited to): antibiotic use, type and dosage, flushing regime, continuous or intermittent intravenous fluid administration, dressing and other securement types, presence of extension tubing or 3-way taps, catheter type and size. Details will be collected for all peripheral venous catheters the patient receives , as well as any subsequent central venous catheters during their hospital admission. Participants will be monitored until discharge from hospital.

Sponsors

Griffith University
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(1) Cancer Care Services inpatient (2) Patient able to provide informed consent (3) PVC inserted within 48hours of admission

Exclusion criteria

(1) Patients who are on a care of the dying pathway (2) Non-English speaking background (NESB) without an available interpreter (3) Previous enrolment in the study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 18, 2026